Literature DB >> 12135834

The role of Chlamydia trachomatis in prostatitis.

W Weidner1, Th Diemer, P Huwe, H Rainer, M Ludwig.   

Abstract

Ascending chlamydial infections have been thought to be an infective cause of prostatitis for the last three decades. Unfortunately, the definitive association between isolation of an infective agent and its prostatic origin is limited by various factors, although modern techniques of molecular biology for identification of the microorganisms are available. Two major problems are: (1) diagnostic material passing the urethra may reflect only urethral contamination, (2) prostatic biopsy specimens from the gland may also contain urethral material. The ejaculate has the same limitations, and an ideal test for detection of Chlamydia species in ejaculate specimens is not available yet. Investigations for local chlamydial IgA-antibodies may be useful; the overlap with Chlamydia pneumoniae and Chlamydia psittaci means a clear differentiation on an type-specific basis is necessary, which is normally provided by the 'elaborate' microimmunofluorescence test. Modern p-ELISAs using major outer membrane protein parts as antigens may deliver identical results in the future. In the follow-up of standardized prostatitis patients, a combination of such urological tests in EPS and seminal plasma combined with genital chlamydial DNA material, may further elucidate the chlamydial aetiology of prostate infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135834     DOI: 10.1016/s0924-8579(02)00094-8

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  15 in total

Review 1.  [Urogenital chlamydial infections in women and men].

Authors:  A Clad; W Krause
Journal:  Hautarzt       Date:  2007-01       Impact factor: 0.751

2.  Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis.

Authors:  Tommaso Cai; Sandra Mazzoli; Francesca Meacci; Vieri Boddi; Nicola Mondaini; Gianni Malossini; Riccardo Bartoletti
Journal:  J Microbiol       Date:  2011-06-30       Impact factor: 3.422

Review 3.  Chlamydial infections in urology.

Authors:  Florian M E Wagenlehner; Wolfgang Weidner; Kurt G Naber
Journal:  World J Urol       Date:  2006-01-19       Impact factor: 4.226

4.  Susceptibility of prostate epithelial cells to Chlamydia muridarum infection and their role in innate immunity by recruitment of intracellular Toll-like receptors 4 and 2 and MyD88 to the inclusion.

Authors:  Juan Pablo Mackern-Oberti; Mariana Maccioni; Cecilia Cuffini; Gerardo Gatti; Virginia E Rivero
Journal:  Infect Immun       Date:  2006-09-05       Impact factor: 3.441

Review 5.  Role of bacteria in oncogenesis.

Authors:  Alicia H Chang; Julie Parsonnet
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 6.  [Chlamydia infections of the male: what is relevant for urologists?].

Authors:  W Weidner; F M E Wagenlehner; T Diemer
Journal:  Urologe A       Date:  2006-12       Impact factor: 0.639

7.  Sexually transmissible infections and prostate cancer risk.

Authors:  Wen-Yi Huang; Richard Hayes; Ruth Pfeiffer; Raphael P Viscidi; Francis K Lee; Yun F Wang; Douglas Reding; Denise Whitby; John R Papp; Charles S Rabkin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

Review 8.  Chronic pelvic pain syndrome and voiding dysfunction.

Authors:  Werner W Hochreiter; Sebastian Z'Brun
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 3.092

9.  Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges.

Authors:  Brandie D Taylor; Catherine L Haggerty
Journal:  Infect Drug Resist       Date:  2011-01-20       Impact factor: 4.003

10.  The evaluation of markers of prostatic inflammation and function of the prostate gland in patients with chronic prostatitis.

Authors:  Bozena Zdrodowska-Stefanow; Iwona Ostaszewska-Puchalska; Jerzy Badyda; Zofia Galewska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-07-29       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.